Veracyte(VCYT) - 2022 Q1 - Earnings Call Presentation

(veracyte. Q1 2022 Business & Financial Presentation May 3, 2022 Disclaimer This presentation contains forward-looking statements, including, but not limited to, our statements related to our expected total revenue and other financial and operating results for 2022 and our plans, objectives, expectations (financial and otherwise) or intentions with respect to our Prosigna, Afirma, Percepta, Envisia, LymphMark, Decipher Prostate, Percepta Nasal Swab, Percepta Genomic Atlas and Decipher Bladder tests and prod ...